Nucana Plc Adr (NCNA)

May 08, 2025

Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Benzinga

May 08, 2025

May 06, 2025

NuCana prices $7 million direct offering of ADSs and warrants - Investing.com

May 06, 2025

May 06, 2025

NuCana prices $7 million direct offering of ADSs and warrants By Investing.com - Investing.com India

May 06, 2025

May 03, 2025

New Outlook On NuCana plc ADR - Stocksregister

May 03, 2025

Apr 25, 2025

NCNA’s Stock Journey: What Investors Need to Know About NuCana plc ADR’s Performance - investchronicle.com

Apr 25, 2025

Apr 25, 2025

Do investors need to be concerned about Cadiz Inc (CDZI)? - uspostnews.com

Apr 25, 2025

Apr 25, 2025

Natera Inc (NTRA) deserves closer scrutiny - uspostnews.com

Apr 25, 2025

Apr 25, 2025

Weave Communications Inc (WEAV) produces promising results - uspostnews.com

Apr 25, 2025

Apr 25, 2025

Investing in NuCana plc ADR (NCNA) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com

Apr 25, 2025

Apr 25, 2025

Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season? - Nasdaq

Apr 25, 2025

Apr 25, 2025

Post-Trade Analysis: NuCana plc ADR (NCNA) Slides -26.97, Closing at 0.65 - DWinneX

Apr 25, 2025

Apr 25, 2025

Closing Bell Recap: Yxt.Com Group Holding Ltd. ADR (YXT) Ends at 0.56, Reflecting a -14.42 Downturn - DWinneX

Apr 25, 2025

Apr 25, 2025

In the Green: Gogoro Inc (GGR) Closes at 0.26, Up/Down 0.08 from Previous Day - DWinneX

Apr 25, 2025

Apr 25, 2025

Daily Market Movement: Tivic Health Systems Inc (TIVC) Sees a 1.88 Increase, Closing at 7.04 - DWinneX

Apr 25, 2025

Apr 09, 2025

RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks - Barchart.com

Apr 09, 2025

Mar 12, 2025

Stock Update - Investorsobserver

Mar 12, 2025

Nov 25, 2024

NuCana Reports Strong Phase 2 Data: 75% Disease Control in Melanoma Trial, Lower Q3 Loss - StockTitan

Nov 25, 2024

Sep 17, 2024

NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study - Yahoo Finance

Sep 17, 2024

Sep 03, 2024

Oppenheimer slashes NuCana stock target, remains Outperform on optimism for upcoming trials - Investing.com

Sep 03, 2024

Aug 29, 2024

NuCana Ends Phase 2 Cancer Study, Focuses on Promising Treatments - TipRanks

Aug 29, 2024

Jul 22, 2024

NuCana shares receive $150 stock PT at Oppenheimer on upbeat trial prospects - Investing.com

Jul 22, 2024

Mar 27, 2024

NuCana plc Announces Reverse ADS Split - TipRanks

Mar 27, 2024

Jan 03, 2024

NuCana: Potential Turnaround In 2024 But Risky - Seeking Alpha

Jan 03, 2024

Oct 05, 2022

Here's Why NuCana PLC Sponsored ADR (NCNA) is Poised for a Turnaround After Losing 26.5% in 4 Weeks - Yahoo Finance

Oct 05, 2022

Mar 04, 2022

Down 57.3% in 4 Weeks, Here's Why You Should You Buy the Dip in NuCana PLC Sponsored ADR (NCNA) - Nasdaq

Mar 04, 2022

Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021

Jan 11, 2021

NuCana (NCNA) Looks Good: Stock Adds 5.7% in Session - Yahoo Finance

Jan 11, 2021

Jun 01, 2020

Will NuCana Continue to Surge Higher? - Nasdaq

Jun 01, 2020

Sep 29, 2017

NCNA Stock Price and Chart — NASDAQ:NCNA - TradingView

Sep 29, 2017

Sep 24, 2017

NuCana PLC Stock Price Today | NASDAQ: NCNA Live - Investing.com

Sep 24, 2017